Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

36results about How to "Achieve targeted release" patented technology

Hydrogel for treating ischemic brain injury and preparation method thereof

ActiveCN119424318Ahigh activityachieve targeted releaseAntipyreticAnalgesicsInjury brainMicrosphere
The invention relates to hydrogel for treating ischemic brain injury and a preparation method thereof. The hydrogel is prepared from the following raw materials: methylacryloylated hyaluronic acid, methylacryloylated gelatin, curcumin loaded HA-PPS (Hydroxypropyl-Polyphenylene Sulfite) nano-micelles and dendrobium polysaccharide loaded sodium alginate microspheres. Through combination of a nanotechnology and an intelligent response material, HA-PPS is adopted to load curcumin and sodium alginate microspheres are adopted to encapsulate dendrobium polysaccharide, so that the drug activity can be more effectively protected, the drug is protected to penetrate through a blood brain barrier and be accurately delivered to a brain injury area, and targeted release of the drug is realized; the anti-oxidation and anti-inflammatory effects are better under the combined action of the curcumin and the dendrobium polysaccharides, and meanwhile, a slow release function is also achieved.
Owner:BEOGENE BIOTECH GUANGZHOU

Preparation method of nano-material coated antibacterial peptide

The invention discloses a preparation method of nano material coated antibacterial peptide, and relates to the technical field of medical chemistry and materials. The invention aims to solve the problem that the antibacterial peptide is easy to damage and even inactivate due to the acidic environment and some proteases when entering the acidic environment such as the stomach. The preparation method specifically comprises the following steps: freeze-drying 5-10 parts of broad-spectrum antibacterial peptide for 3 days, washing all the broad-spectrum antibacterial peptide until the broad-spectrum antibacterial peptide is fluffy and spongy, mixing the fluffy and spongy broad-spectrum antibacterial peptide with 5-10 parts of a calcium chloride solution, shaking in a shaking table after mixing to obtain a first mixed solution, adding 1-5 parts of an enteric polymer into the first mixed solution, and shaking in the shaking table after mixing to obtain a second mixed solution; a second mixed solution is obtained; according to the method, the antibacterial peptide is independently coated in the polymer nano-material, the antibacterial peptide is protected by the polymer nano-material, and then the coating layer of the polymer nano-material can release the antibacterial peptide in a targeted manner after being removed at a target position through related signals such as pH value, so that the targeted release of the antibacterial peptide is realized.
Owner:NORTHWESTERN POLYTECHNICAL UNIV

Intestinal targeted release puerarin microcapsule as well as preparation method and application thereof

ActiveCN119074685ADoes not impair functional activityGood embedding effectOrganic active ingredientsDigestive systemFreeze-dryingPuerarin
The invention belongs to the technical field of puerarin microcapsule embedding, and discloses an intestinal targeted release puerarin microcapsule as well as a preparation method and application thereof. The preparation method comprises the following steps: by taking yeast beta-glucan as an embedding carrier, embedding puerarin into the yeast beta-glucan under the ultrasonic action in a solution environment to form a core material, so as to obtain a first mixed solution; sodium alginate powder is added into the first mixed solution under the stirring effect, the surface of the core material is coated with sodium alginate, a layer of wall material is formed, and a second mixed solution is obtained; and dropwise adding the second mixed solution into a coagulating bath by adopting a sharp hole method, curing, washing, performing solid-liquid separation, and performing freeze drying to obtain the puerarin microcapsule. The preparation method is simple and easy to operate, medicinal and edible substances are selected as raw materials, toxic and harmful chemical preparations such as cross-linking agents are not introduced, chemical pollution and potential health risks are avoided, and the puerarin microcapsule has good intestinal tract slow release effect and oxidation resistance.
Owner:LANZHOU UNIV

Application of NR3A as protein target in screening or preparing medicine for preventing and / or treating depression-like behavior

PendingCN119318706AHigh expressionreduce depressionCompound screeningApoptosis detectionStainingNeural biology
The invention belongs to the field of neurobiology and drug research and development, and discloses application of NR3A as a protein target in screening or preparing drugs for preventing and / or treating depression-like behaviors. According to the invention, the expression of NR3A in hippocampus is enhanced by stereotactic injection of adeno-associated virus containing Grin3a gene. A chronic constraint stress (CRS) is adopted to induce a depressive mouse, and a sucrose preference test (SPT), a forced swimming test (FST) and an open field test (OFT) are adopted for identification. The expression of proteins such as NR3A, calpain 2 (Calpain2), neuron nitric oxide synthase (nNOS), 3-nitrotyrosine (3-NT), an NLRP3 inflammation complex and the like is detected by WesternBlot; and performing DHE staining to detect reactive oxygen species (ROS). By enhancing hippocampus NR3A expression, depression-like behaviors induced by CRS can be improved, signal cascade activated by calcium is inhibited, ROS generation and 3-NT expression are reduced, and neuroinflammation driven by NLRP3 inflammasomes is inhibited. The NR3A participates in depression-like behaviors induced by CRS, and the mechanism of the NR3A is related to calcium homeostasis regulation, ROS generation and inflammatory response driven by NLRP3 inflammasomes.
Owner:CHONGQING MEDICAL UNIVERSITY

Reduction response type photopolymerizable supramolecular monomer as well as preparation method and application thereof

The invention belongs to the technical field of preparation of tumor targeted drug carriers, and particularly discloses a reduction response type photopolymerizable supramolecular monomer as well as a preparation method and application thereof. According to the reduction response type photopolymerizable supramolecular monomer disclosed by the invention, a disulfide bond of cystamine dihydrochloride is taken as a molecular skeleton center, one end of the disulfide bond is substituted by hydrophilic element dendritic alkoxy ether, and hydrophobic element triphenylamine or tetraphenylethylene with an aggregation-induced emission (AIE) effect is introduced into the other end of the disulfide bond. The prepared supramolecular monomer can be self-assembled in a solution to form a supramolecular polymer, disulfide bonds can be broken under the action of a reducing compound, and targeted release of a loaded drug in a tumor microenvironment is achieved. Under the irradiation of ultraviolet light, partial crosslinking can be realized, so that the stability of the polymer is improved.
Owner:JINING MEDICAL UNIV

Crystal sphere probiotics capable of realizing targeted release in colon as well as preparation method and application of crystal sphere probiotics

The invention belongs to the technical field of probiotics, and particularly relates to crystal ball probiotics capable of being released in colon in a targeted mode and a preparation method and application of the crystal ball probiotics. The crystal ball probiotics comprise a core material and a wall material, the weight ratio of the core material to the wall material of the crystal ball is (0.1-2): 1, and the core material comprises the following components in parts by weight: 65-90 parts of oil, 1-25 parts of probiotic powder, 0.1-10 parts of an antioxidant and 1-10 parts of a stabilizer; the wall material is prepared from the following components in parts by weight: 3 to 55 parts of gel, 0.1 to 10 parts of plasticizer and 40 to 93 parts of purified water. According to the crystal ball probiotics capable of being released in the colon in the targeted mode, the outer layer of the crystal ball probiotics is a composite hydrophilic colloid layer, and the inner layer of the crystal ball probiotics is an oil-phase probiotics layer. The composite hydrophilic colloid layer can resist gastric juice and intestinal juice and can be dissolved in colon fluid at the same time, so that targeted release of probiotics in the oil-phase probiotic layer is achieved, and the probiotics can be effectively absorbed and utilized.
Owner:TIBET ANGEL ZHUFENG BIOTECHNOLOGY CO LTD +1

A rock mass directional fracturing device and a rock mass directional blasting method

The embodiment of the present invention provides a rock mass directional fracturing device and a rock mass directional blasting method, which relates to the field of mining engineering blasting. It includes: a main pipe, a heating rod, a filling head and an adapter; the filling head is connected to the first end of the main pipe, the adapter is connected to the second end of the main pipe, and a first terminal is provided on the adapter; a filling channel for filling carbon dioxide into the main pipe is provided on the filling head, and a needle valve for opening and closing the filling channel is provided in the filling channel; the heating rod includes a base and a paper tube provided on the base, a hole is reserved on the base, a second terminal is provided in the hole, the second terminal extends in the paper tube, a threading hole is provided at one end of the paper tube away from the base, a wire is provided on the second terminal, and one end of the paper tube is located in the paper tube, the wire is axially arranged in the paper tube, and is led out from the threading hole to the second terminal of the adapter; a groove is also provided in the axial direction of the side wall of the main pipe. It is convenient to realize the directional blasting of the rock mass, thereby improving the blasting effect.
Owner:UNIV OF SCI & TECH BEIJING

Filter rod, filter rod fastener implantation device and cigarette filter tip

ActiveCN114431523Bachieve targeted releaseSimple structureTobacco smoke filters
The present invention discloses a filter rod, a filter rod fastener implanting device and a cigarette filter tip, which are intended to implant fasteners into the filter rod in a specific order to achieve directional release of water-soluble flavors. The filter rod fastener implanting device comprises a frame, on which a base rod conveying disk, a fastener conveying disk, a composite disk and a gap-eliminating disk are rotatably arranged, and a plurality of first card slots and second card slots are alternately arranged in the circumferential direction of the composite disk. The frame is also provided with a first paddle for connecting the filter base rod on the base rod conveying disk to the first card slot and a second paddle for connecting the fastener on the fastener conveying disk to the second card slot, and a guide plate is also provided on the frame, one side of the guide plate is arc-shaped, and a gap-eliminating conveying channel is formed between the gap-eliminating disk and the arc-shaped surface of the guide plate, and a third paddle is also provided at the top of the guide plate for alternately connecting the fastener and the filter base rod on the composite disk to the gap-eliminating conveying channel.
Owner:CHINA TOBACCO HUNAN IND CORP

A kind of gallwood extract gel and its preparation process

The invention provides a gallwood extract gel and a preparation process thereof. The gallwood extract gel comprises the following raw materials in parts by weight: 1.8-5.8 parts of gallwood extract, 12.9-39.8 parts of aqueous gel matrix, 1.6-5.9 parts of penetration enhancer, 2.1-3.9 parts of nanocarriers and 1.2-1.9 parts of oligopeptides. The gallwood extract drug, the aqueous gel matrix, the penetration enhancer and the carrier nanomaterials are scientifically proportioned to synergistically exert the drug properties, and under the interaction between the stratum corneum and lipids of the skin, the diffusion resistance of the drug in the stratum corneum is reduced, the fluidity is enhanced, the onset time of the drug is shortened, the active ingredients of the drug in the gel are sustained-released within a certain period of time, and a higher permeability is achieved, so as to play a quick-acting role, and the highest permeability reaches 96.2% at 36 hours.
Owner:HAINAN VOCATIONAL TECHN COLLEGE

Preparation method of astaxanthin cordyceps sinensis fine powder

The application provides a preparation method of astaxanthin cordyceps militaris fine tablets, comprising the following steps: subjecting cordyceps militaris fruiting bodies to supercritical CO2 extraction treatment to separate a cordyceps militaris terpene component; mixing Haematococcus pluvialis powder and edible vegetable oil, adding the cordyceps militaris terpene component and rosemary extract, and cooling and forming to obtain an astaxanthin-cordyceps militaris terpene blend; crushing the residue after extraction, adding purified water and a composite enzyme preparation to perform enzymolysis to obtain an enzymolysis liquid; adding a chitosan quaternary ammonium salt solution, centrifuging after flocculation, vacuum drying, and crushing to obtain cordyceps militaris active powder; mixing and granulating raw materials to obtain granulation particles; uniformly mixing the granulation particles with xylitol and microcrystalline cellulose, and pressing into tablets; and placing the tablets in a coating machine for coating. The application realizes efficient retention of active ingredients, improvement of safety and stability of product quality through the cooperation of multiple technologies such as supercritical CO2 extraction, enzymolysis flocculation, low-temperature fluidized bed granulation and hot melt coating.
Owner:YUNNAN AIERKANG BIOTECH

Double-sensitive type co-loaded emodin and chlorambucil micelle as well as preparation method and application of double-sensitive type co-loaded emodin and chlorambucil micelle

The invention belongs to the field of nano-drug delivery systems, and particularly relates to a double-sensitive type co-loaded emodin and chlorambucil micelle as well as a preparation method and application thereof. The structural formula of the polymer is as follows: polyethylene glycol monomethyl ether, p-hydroxymethyl phenylboronic acid pinacol ester and emodin grafted dendritic polymer p (mPEG-co-HPBE-co-EMD) are designed and synthesized by taking polymethacrylate as a connecting unit, and the dendritic polymer p (mPEG-co-HPBE-co-EMD) is used for entrapment of chlorambucil. The co-drug-loaded polymeric micelle can be used for co-delivery of the emodin and the chlorambucil, improves the water solubility of drugs, has proper particle size and ROS / pH dual sensitivity, can realize targeted release of the emodin and the chlorambucil at tumor sites, and realizes collaborative treatment of chemotherapy and oxidation therapy. In the # imgabs0 # formula, n = 30-85, and x: y: z = 1: (2-5): (1-3).
Owner:SHENYANG PHARMA UNIV

Special feed for fattening pigs rich in functional amino acids and process for its preparation

The application discloses a special feed for fattening pigs rich in functional amino acids, which comprises the following components in parts by weight: a core functional amino acid composition 3-5 parts, a low-soybean meal multi-protein matrix 60-70 parts, a nutrition synergistic component 20-25 parts, an anti-nutritional factor degradation agent 1-2 parts, and a micro-ecological and plant extract component 1-2 parts. A preparation method comprises the following steps: obtaining the low-soybean meal multi-protein matrix by pretreating raw materials; preparing the core functional amino acid microcapsule; mixing the basic materials and then performing low-temperature section granulation; after cooling, mixing the micro-ecological and plant extract component at low temperature; and finally screening and removing impurities and unqualified particles to obtain the finished product. The application optimizes the amino acid ratio and the preparation process, protects the activity of the amino acids, adapts to different growth stages of the fattening pigs, improves the growth performance and carcass quality, improves the raw material digestion rate, reduces nitrogen emission, and has strong applicability.
Owner:三明傲农生物科技有限公司 +1

Preparation method of diet for improving sleep by using rice germ extract

The invention discloses a preparation method of a diet for improving sleep by using a rice germ extract, which is used in the field of diet products and comprises the following components: the rice germ extract (containing SOD enzyme), a natural plant extract, melatonin, a sweetening agent, an acidulant, a vitamin B group and minerals. The proportions of the rice germ extract (containing SOD enzyme), the natural plant extract, the melatonin, the sweetening agent, the acidulant, the vitamin B group and the mineral substances are 50%, 20%, 5%, 15%, 5%, 2% and 3% respectively. The diet is prepared from the natural rice germ extract and other natural components, the diet can effectively regulate the biological clock of a human body and secretion of melatonin, improve the sleep quality and contribute to supplementing nutrients required by the body, and in the preparation process, the rice germ extract and other components are wrapped by adopting a microcapsule or liposome wrapping technology to realize targeted release, so that the diet has a good application prospect. The wrappings can release active ingredients in the wrappings in a specific environment (such as in intestinal tracts).
Owner:ZHONGDITAIKE (NANJING) BIOTECHNOLOGY CO LTD

An in-situ oxygen-controlled composite scraper and a laser selective melting device equipped with the in-situ oxygen-controlled composite scraper.

PendingCN122077040ARealize active regulationPrecisely controllable regulation of oxidation behaviorAdditive manufacturing apparatusIncreasing energy efficiencyManufacturing technologyAdditive layer manufacturing
This invention belongs to the technical field of additive manufacturing technology and discloses an in-situ oxygen-controlled composite scraper and a laser selective melting device equipped with the in-situ oxygen-controlled composite scraper. The bottom of the composite scraper includes a second scraper (16), an air jet unit, and a first scraper (18) arranged sequentially along the powder spreading direction. It has an internal gas storage chamber (15) and a powder drop chamber (19). The first scraper is used to evenly spread the powder raw material to form an initial powder layer. The air jet unit performs in-situ oxidation treatment on the surface of the initial powder layer by spraying oxygen-containing gas. The second scraper is used to level and compact the powder layer after the in-situ oxidation treatment. This invention improves the composition and structure of the composite scraper and utilizes the overall cooperation of the first scraper, the air jet unit, and the second scraper to generate a synergistic mechanism of powder spreading, in-situ oxidation, and secondary compaction, breaking through the process limitation that it is difficult to construct oxide dispersion-strengthened structures in-situ during additive manufacturing.
Owner:HUAZHONG UNIV OF SCI & TECH

A method for preparing cordycepin liposome multi-responsive microspheres

ActiveCN117462498Bachieve targeted releaseRealize system multi-functionalityOrganic active ingredientsAntimycoticsPeristaltic pumpCholesterol
The present invention provides a method for preparing cordycepin liposome multi-responsive microspheres. The method comprises the following steps: dissolving lecithin and cholesterol in anhydrous ethanol to obtain a lipid phase; using an aqueous solution containing cordycepin as an aqueous phase; slowly injecting the lipid phase into the aqueous phase, removing the ethanol, and then performing ice bath ultrasound to obtain cordycepin liposomes; mixing cordycepin liposomes, a magnetic gelatin solution, and an aqueous solution of sodium alginate, and stirring evenly to obtain a cordycepin liposome multi-responsive microsphere stock solution; using a peristaltic pump to uniformly pump the cordycepin liposome multi-responsive microsphere stock solution into a high-voltage electrostatic spray device, spraying it into a CaCl2 solution for solidification, filtering out the microspheres, and obtaining cordycepin liposome multi-responsive microspheres. The cordycepin liposome microspheres with temperature / pH / salt ion concentration / magnetic multi-responsiveness prepared by the present invention realize the multifunctionality of the system and the controlled enrichment and targeted release of cordycepin.
Owner:NAN JING XIAN CAO JING HUI JI SHU YAN JIU ZHONG XIN

Compound as well as preparation method and application thereof

The invention discloses a compound as well as a preparation method and application thereof, and belongs to the technical field of drug delivery systems and tumor targeted therapy. The compound as shown in the formula 1 is novel and unique in structure, can be used as an anti-melanoma prodrug compound, realizes targeted release and collaborative treatment of drugs (Devistat and TPEDCH) under laser irradiation, has a fluorescence imaging function, is used for monitoring the distribution and activation process of the drugs in tumor cells in real time, and has a good application prospect. The traditional Chinese medicine composition has excellent anti-melanoma effect and low toxic and side effects. Formula 1.
Owner:NINGBO FIRST HOSPITAL

Modified children's dietary fiber based on microcapsule embedding and ultra-micro homogenization emulsification and preparation method thereof

PendingCN122498657ASignificant taste and flavor advantagesEliminates inherent bitterness
This invention discloses a modified children's dietary fiber based on microcapsule encapsulation and ultra-micro homogenization emulsification and its preparation method, which is prepared according to the following steps: (1) Raw material pretreatment: plant fiber is crushed; (2) Enzymatic modification: the fiber powder is prepared into a fiber suspension slurry, cellulase is added for enzymatic hydrolysis, and the modified fiber slurry is obtained after enzyme inactivation and cooling; (3) Composite wall material preparation: maltodextrin or whey protein and gum arabic are weighed, dissolved in deionized water, and natural antioxidants are added; (4) Homogenization emulsification and microcapsule encapsulation: the modified fiber slurry obtained in step (2) is dispersed in the wall material solution in step (3) as the core material, and homogenized using a two-stage gradient high pressure treatment. After homogenization, the product is obtained by spray drying or fluidized bed encapsulation and solidification. Through nanoscale reshaping and directional encapsulation, the rough taste of dietary fiber is completely eliminated, unpleasant flavors are masked, and natural antioxidants are used to improve the stability and intestinal bioavailability of the product.
Owner:CHONGQING MEDICAL & PHARMA COLLEGE

Feline triple yolk antibody preparation, preparation method and application thereof

The application discloses a feline panleukopenia virus, feline herpes virus and feline calicivirus yolk antibody preparation and a preparation method and application thereof. The feline triple yolk antibody preparation comprises a core material, and the core material comprises feline calicivirus yolk antibody, feline panleukopenia virus yolk antibody, feline herpes virus type 1 yolk antibody and probiotics. The application can produce specific neutralization to feline calicivirus, feline panleukopenia virus and feline herpes virus type 1, significantly reduces the infection rate and the severity of clinical symptoms, is stably released in the gastrointestinal tract after oral administration, the antibody activity retention rate is more than 90%, the probiotics synergistically regulate intestinal microecology, enhance the immune response of the body and improve the overall protection efficiency.
Owner:YANAN VOCATIONAL & TECHN COLLEGE

An enteric-targeted controlled-release microalgae pharmaceutical composition, preparation method and application

The application discloses an intestinal-targeted controlled-release microalgae pharmaceutical composition, which comprises a hydrophobic drug, a micellar material and microalgae, wherein the hydrophobic drug is first loaded on the micellar material to form a drug-loaded micelle, the solubility of the hydrophobic drug is improved, and the drug-loaded micelle solution penetrates into the interior of the microalgae cells through a passive water absorption process of dried microalgae instead of being attached to the surface of the microalgae. The natural cell wall of the microalgae itself is solid and acid-resistant, which is used as a first physical barrier to prevent the release of the hydrophobic drug in a gastric acid environment, and the effective concentration and residence time of the hydrophobic drug in the intestinal action site are significantly improved, so that the treatment effect is better, and the intestinal disease and kidney disease drug can be prepared.
Owner:INNOVATION CENTER OF YANGTZE RIVER DELTA ZHEJIANG UNIVERSITY

Functional nutritional supplement containing calcium beta-hydroxy-beta-methylbutyrate

The invention relates to the field of formula foods for special medical purposes, in particular to a functional nutritional supplement containing calcium beta-hydroxy-beta-methylbutyrate, which comprises the following raw materials in parts by mass: 2.6-7.7 parts of calcium beta-hydroxy-beta-methylbutyrate; 13.8 to 17.2 parts of compound amino acid; 56 to 78.5 parts of whey protein powder; 0.2 to 0.5 part of vitamin; 0.3 to 0.5 part of hydroxy citric acid; 4.9 to 5.5 parts of functional nano particles; 2.3 to 3 parts of a cyclodextrin inclusion compound; 0.9-1.2 parts of a rhizoma alismatis soup polysaccharide composition; 1-3 parts of inulin; 1-3 parts of lotus leaf pectin polysaccharide (LLP); 0.5 to 0.9 part of hydrophilic fumed silica; the functional nanoparticles, the cyclodextrin inclusion compound, the rhizoma alismatis decoction polysaccharide composition and the calcium beta-hydroxy-beta-methylbutyrate have a synergistic effect, anabolism is enhanced, catabolism is inhibited, the sarcopenia is effectively improved, and the composition has a wide application prospect.
Owner:JIANGSU XIXIN VITAMIN

Low-pressure drug-loading balloon catheter system and pretreatment method for abdominal aortic aneurysm endovascular repair

PendingCN122516511AImprove delivery efficiencyImprove local control efficiency
The application provides a low-pressure drug-loaded balloon catheter system for preoperative treatment of abdominal aortic aneurysm endovascular repair and a pre-treatment method, which comprises a catheter main body, a segmented balloon structure is arranged at the distal end of the catheter main body, a drug-loaded coating structure for realizing biological remodeling of the abdominal aortic aneurysm lesion vessel wall is arranged on the outer surface of the segmented balloon structure, the drug-loaded coating structure releases active drugs for inhibiting the pathological progression of abdominal aortic aneurysm under the action of blood flow, a pressure control system in communication with the segmented balloon structure is arranged on the catheter main body, and the pressure control system is used for low-pressure inflation of the segmented balloon structure and adjustment of injection pressure and flow rate. The application improves the local drug delivery efficiency under the premise of ensuring operation safety through the synergistic design of structural design and drug delivery mechanism, and provides a new preoperative intervention strategy for the treatment of abdominal aortic aneurysm.
Owner:ZHONGSHAN HOSPITAL FUDAN UNIV

Intestinal targeting probiotic emulsion gel capsule and preparation method thereof

PendingCN121867412AFree from the influence of gastric acid environmentachieve targeted releaseDigestive systemUnknown materialsEnzymatic digestionDigestion
The invention discloses an intestinal targeting probiotic emulsion gel capsule and a preparation method thereof. The preparation method comprises the following steps: firstly, preparing an acidic water phase containing probiotics and cationic polysaccharide, and preparing an oil phase containing a hydrophobic solid particle emulsifier and edible oil; the oil phase and the water phase are emulsified at a high speed, and stable emulsion gel is formed on an oil-water interface by utilizing an electrostatic crosslinking effect between the cationic polysaccharide and solid particles; further, edible colloid is used as a shell, and the emulsion gel inner core is packaged through a micro-fluidic technology to prepare the emulsion gel capsule. The emulsion gel disclosed by the invention can effectively resist a gastric acid environment, protect the activity of probiotics and realize targeted release in intestinal tracts by digesting an oil phase through lipase. The capsule is completely made of safe materials approved by FDA, has good stability, machinability and biocompatibility, remarkably improves the oral delivery efficiency of probiotics, and is suitable for the field of functional food and pharmaceutical preparations.
Owner:ZHEJIANG UNIV

Composite viscosity reducer, preparation method and application thereof, and method for responsively demulsifying thick oil produced liquid

The invention relates to the technical field of thick oil emulsification and viscosity reduction exploitation, and discloses a composite viscosity reducer, a preparation method and application thereof, and a method for responsively demulsifying thick oil produced liquid, the composite viscosity reducer contains a cyclodextrin-based surfactant, water and modified graphene oxide; the modified graphene oxide comprises graphene oxide and a grafted polyoxyethylene chain, the chemical formula of the polyoxyethylene chain is-CH2CH (OH) CH2O (CH2CH2O) nCH2CH2OH, and n is any integer selected from 3 to 20; and the cyclodextrin-based surfactant contains a group of-OSO3Na and a group of-OH. The modified graphene oxide provided by the invention has excellent salt resistance and interface performance, and when the modified graphene oxide and a cyclodextrin-based surfactant are used in the composite viscosity reducer, the emulsification and viscosity reduction effects of the viscosity reducer on thick oil can be remarkably improved. And meanwhile, CO2 responsive demulsification of the oil-water emulsion is realized by utilizing pH responsive sites of the composite viscosity reducer.
Owner:CHINA PETROLEUM & CHEMICAL CORP +1

A balloon catheter capable of directional drug release

The present invention discloses a balloon catheter capable of directionally releasing drugs, which relates to the field of drug balloon catheters, and includes a balloon, a catheter, and a handle, wherein the catheter has an axial hollow cavity, the balloon is close to the first end of the catheter, and the handle is located at the second end of the catheter; the balloon is a flap structure, including a first balloon flap and a second balloon flap, wherein the first balloon flap is loaded with drugs, and the second balloon flap is not loaded with drugs or has drugs sprayed on the surface; the handle can be connected to a liquid pump or an air pump. The present invention adopts a multi-cavity structure of the catheter, combined with a special balloon marking method, to improve the maneuverability of the balloon catheter; adopts a flap-type balloon design, to form a drug-loading groove on the balloon surface, so that the drug loading capacity of the balloon is significantly increased; at the same time, by improving the balloon material and structure, the utilization rate of the drug and the accuracy of the treatment are improved, and it has clinical application value.
Owner:WEIMING MEDICAL DEVICES SHANGHAI CORP LTD

Synergistic anticancer application of redox-responsive condensate delivery of jujubein and 3-methyladenine

This invention relates to the synergistic anticancer application of redox-responsive condensates (FFSSFF) for delivering jujube extract and 3-methyladenine. Specifically, this invention relates to the application of redox-responsive condensates in the preparation of targeted drug delivery products, wherein the targeted drug delivery products release drugs in response to glutathione. The active ingredients in the targeted drug delivery products are jujube extract and 3-methyladenine. This invention utilizes an FFSSFF carrier designed based on the LLPS principle, integrating redox-sensitive disulfide bond linkage modules to achieve spatiotemporally controlled drug delivery within a tumor tissue-specific microenvironment with high glutathione concentrations.
Owner:UNIV OF SCI & TECH OF CHINA +1

Whitening and freckle-removing essence and preparation method thereof

The invention relates to the technical field of cosmetics, and discloses a whitening and freckle-removing essence and a preparation method thereof.The whitening and freckle-removing essence is formed by taking additives such as nicotinamide, EDTA, L-lactic acid, citric acid and a baicalein embedding material as main raw materials and mixing the main raw materials, the baicalein embedding material of the whitening and freckle-removing essence contains a coating type structure, and due to the fact that the skin surface carries negative charges, the skin surface is not prone to damage. A coating layer of the baicalein embedding material contains chitosan, so that the baicalein embedding material can be adsorbed on the surface of skin through electrostatic interaction to generate a slow-release effect and further perform targeted release, the whitening effect of the essence can be improved, in addition, after being embedded, baicalein can have good compatibility with other substances in the formula, and in addition, the baicalein embedding material can be used for whitening the skin. The flax aliphatic chain in the structure of the chitosan derivative has excellent anti-oxidation and anti-inflammatory effects, and can reduce the phenomenon of skin scars caused by inflammation.
Owner:GUANGZHOU JIANGXIN BIOTECHNOLOGY RESEARCH CO LTD

Bakuchiol salicylate and application thereof

The invention relates to the technical field of cosmetics, and discloses bakuchiol salicylate and application thereof. The structural formula of the bakuchiol salicylate is as shown in formula I in the specification. According to the bakuchiol salicylate disclosed by the invention, two active molecules are integrated into a brand new chemical entity through a covalent ester bond, so that an easily oxidized phenolic hydroxyl group of bakuchiol and a strongly acidic carboxyl group of salicylic acid are effectively masked, the chemical stability is improved, the bakuchiol salicylate is difficult to oxidize and degrade, the skin irritation is greatly reduced, the lipophilicity is improved, and the skin care effect is good. Compared with simple physical compounding of bakuchiol and salicylic acid in the prior art, by means of the innovative prodrug design, the synergistic breakthrough of stability, safety and efficacy is successfully achieved, and the obvious synergistic effect is shown in the aspects of stability, oxidation resistance, inflammation resistance, whitening, aging resistance and the like.
Owner:NANJING CHEMPION BIOTECHNOLOGY CO LTD

Stain release type bionic marine antifouling paint with topological structure

The invention discloses a fouling release type bionic marine antifouling paint with a topological structure. An anionic monomer, a hydrophilic amide monomer, a carboxyl curing agent and an organic solvent are subjected to an in-situ ester cross-linking reaction to prepare a modified curing agent with a soft and hard segment synergistic topological structure. In the final curing coating, the modified curing agent and the film-forming resin are subjected to a cross-linking reaction, the topological structure entropy of the coating is effectively improved through the soft and hard segment structure of the modified curing agent, and therefore coordination between cohesive force and adhesive force of the curing coating is achieved, and the curing coating is endowed with good adhesive performance through polar groups introduced by the modified curing agent; therefore, the adhesive can be excellently bonded on various base materials and intermediate paints. Meanwhile, a polar group introduced by the modified curing agent can drive the inert bionic mucus to migrate and release to the surface of the coating in the three-dimensional network structure, so that a good antifouling effect is achieved. The coating can be applied to antifouling of marine facilities, and is particularly suitable for various marine facilities immersed in a seawater environment for a long time.
Owner:CHANGSHU INSTITUTE OF TECHNOLOGY

Application of damage responsive polymer nanoparticle loaded polypeptide in treatment of cardiovascular diseases

The invention relates to the technical field of biological medicine, in particular to application of damage-responsive polymer nanoparticle loaded polypeptide to treatment of cardiovascular diseases. The preparation method comprises the following steps: sequentially adding sodium hydroxide and a toluenesulfonyl chloride solution into a polyethylene glycol methyl ether solution to react, and extracting to remove a solvent to obtain PEG-toluenesulfonyl; sequentially adding a potassium thioacetate solution and trimethylamine into the PEG-tosyl solution, and then incubating to obtain polyethylene glycol thioacetate; and sequentially adding sodium methoxide, propylene sulfide and iodoacetamide into the polyethylene glycol thioacetate solution, reacting, and precipitating to obtain the product. The invention provides an innovative method for delivering peptide drugs for myocardial infarction by using nano-particles sensitive to peroxide generated by injury. The NPs not only can deliver the peptide medicine to the infarcted heart, but also can directly reduce the peroxide level of the injured part, and has a more effective treatment effect on the infarcted heart compared with a naked peptide.
Owner:HANGZHOU NOVELPEPTIDE BIOTECH CO LTD

GMO-GO-PEG-MAN nano-drug delivery material as well as preparation method and detection method thereof

The invention provides a GMO-coated GO-PEG-MAN nano-drug delivery material as well as a preparation method and a detection method thereof. A drug is germacrone, GO is subjected to PEG modification, MAN terminal targeting molecular modification is performed, and germacrone is loaded by utilizing a hydrophobic region of GO; hydroxyl groups and epoxy groups are distributed on graphite single sheets of graphene oxide, carboxyl groups and carbonyl groups are introduced to the edges of the graphite single sheets, in 8Arm-PEG-NH2, under the action of EDC, the carboxyl groups and the amino groups react to form amido bonds, and the amido bonds are coupled to the surface of the graphene oxide; the D-mannose can be combined with a mannose receptor on the surface of the macrophage, so that the drug delivery material targeting the macrophage is obtained. The GMO (at) GO-PEG-MAN can enhance the uptake of germacrone by macrophages, and slowly releases drugs to delay the reduction of the intracellular germacrone concentration and maintain the intracellular high-concentration germacrone level, so that the drug effect is remarkable.
Owner:THE FIRST AFFILIATED HOSPITAL OF ZHEJIANG CHINESE MEDICAL UNIVERSITY